Windgap Medical

Executive Summary

Windgap Medical is a private drug delivery device company headquartered in Watertown, Massachusetts, focused on developing innovative autoinjector platforms for complex injectable therapies. Founded in 2013, the company's technology addresses key challenges in drug administration, including lyophilized powder reconstitution, sequential liquid delivery, high-viscosity medications, and large-volume injections. By automating and accelerating the path to market for combination drug-device products, Windgap aims to improve patient experience and expand treatment options for chronic and acute conditions. The company's platforms are designed to be compatible with a range of drug formulations, offering flexibility to pharmaceutical partners seeking to differentiate their injectable products. While Windgap has not yet commercialized any products or disclosed significant financial backing, its niche focus on solving complex delivery problems positions it as a potential partner for biopharma firms developing challenging therapeutics.

Upcoming Catalysts (preview)

• Q4 2026Pharmaceutical Partnership or Licensing Deal60% success
• Q3 2026Completion of Key Feasibility Study or Prototype Milestone80% success
• Q1 2027Series B or C Financing Round50% success